Clinical Trials Logo

Pharyngitis clinical trials

View clinical trials related to Pharyngitis.

Filter by:

NCT ID: NCT03098667 Completed - Postoperative Pain Clinical Trials

Laryngeal Mask Airway (LMA) Protector for Minimally Invasive Thyroidectomy

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

The patients will be allocated to 2 groups: the LMA group and the endotracheal tube (ET) group. Airway management will be done with the LMA Protector for the patients of the LMA group and with the classic endotracheal tube for the patients of the ET group. The main purpose of the study is to determine if the application of the LMA Protector causes less laryngopharyngeal symptoms than the endotracheal tube after minimally invasive thyroidectomy. The secondary purpose is to confirm that the LMA Protector is a safe alternative airway management device for minimally invasive thyroidectomy.

NCT ID: NCT03095521 Completed - Sore Throat Clinical Trials

A Local Clinical Study for the Comparative Evaluation of Efficacy and Safety of Angal, Lozenges [Menthol] and ANTI-ANGIN® FORMULA, Lozenges, in Treatment of Patients With a Sore Throat

Start date: February 22, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study was to evaluate no less therapeutic efficacy and safety of the Angal, lozenges [Menthol], 1 mg + 5 mg (Sandoz dd, Slovenia) compared to ANTI-ANGIN® FORMULA, lozenges, 0,2 mg + 2 mg + 50 mg (LLC "Valeant", Russia) in treatment of patients with uncomplicated acute infectious and inflammatory diseases of the pharynx, accompanied by a sore throat.

NCT ID: NCT03095508 Completed - Sore Throat Clinical Trials

Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FORMULA, Topical Metered Spray in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied by a Sore Throat

Start date: February 22, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study was to evaluate no less therapeutic efficacy and safety of the Angal S, topical spray [Menthol], 0,5 mg + 2 mg (Sandoz dd, Slovenia) compared to ANTI-ANGIN® FORMULA, topical metered spray, 0,12 mg + 0,24 mg (LLC "Valeant", Russia) in treatment of patients with uncomplicated acute infectious and inflammatory diseases of the pharynx, accompanied by a sore throat.

NCT ID: NCT03074968 Completed - Clinical trials for Intubation Complication

Effect of Benzydamine Hydrochloride to Postoperative Sore Throat in Pediatric Patients

Start date: March 8, 2017
Phase: Phase 4
Study type: Interventional

This study is designed to examine the effect of benzydamine hydrochloride to postoperative sore throat in pediatric patients. We will spray benzydmaine hydrochloride or normal saline at oral cavity and the tip of endotracheal tube, than compare the prevalence of postoperative sore throat using smartphone application in pediatric patients.

NCT ID: NCT03055728 Completed - Clinical trials for Streptococcal Infections

Rapid Strep Testing in Children With Recent Streptococcal Pharyngitis

Start date: May 9, 2013
Phase:
Study type: Observational

The purpose of this study is to determine if the rapid antigen detection test for Group A streptococcal pharyngitis diagnosis might yield higher rates of false positive results in patients who have been treated for GAS pharyngitis within 28 days of the test.

NCT ID: NCT03037957 Completed - Clinical trials for Pharyngitis Bacterial

A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients

Start date: January 9, 2017
Phase: N/A
Study type: Observational

A multi-center evaluation to assess the diagnostic sensitivity and specificity of the ARIES Group A Strep Assay will be established through a method comparison using prospectively collected, de-identified, clinical samples collected during the enrollment period.

NCT ID: NCT02848365 Completed - Pain Clinical Trials

Incidence and Severity of Postoperative Sore Throat And Intubation Response by Using Different Devices for Endotracheal Intubation

Start date: June 2011
Phase: N/A
Study type: Interventional

Postoperative sore throat (POST) is a common problem following the use of endotracheal intubation during general anaesthesia. It leads to dissatisfaction and discomfort after surgery and can delay a patient's return to normal routine activities. POST has been rated by patients as the eighth most adverse effect in the postoperative period. The incidence of sore throat after endotracheal intubation varies from 14.4-90%. Laryngoscopy and tracheal intubation also leads to hemodynamic stress response. The response can be deleterious in patient with or without cardiac disease. It is related to the degree of manipulation of the airway during endotracheal intubation and has been studied during intubation for some equipment used for endotracheal intubation

NCT ID: NCT02723890 Completed - Pharyngitis Clinical Trials

The Efficacy and Safety of Using the Novel Tyto Device

Start date: July 2016
Phase: N/A
Study type: Interventional

To investigate the efficacy and safety of using the novel Tyto device for remote physical examination by co-investigators as compared to a standard medical physical examination by physicians.

NCT ID: NCT02682134 Completed - Sore Throat Clinical Trials

Sore Throat Prevention Following Intubation

Start date: November 2015
Phase: Phase 4
Study type: Interventional

The aim of this interventional study is to find out the incidence of sore throat among intubated patients in Jordan university hospital and to find out which is preventive and effective method to decrease sore throat;is it xylocaine gel on endotracheal cuff as lubricant versus dexamethasone 8 mg intravenously or both.

NCT ID: NCT02669446 Completed - Clinical trials for Acute Viral Pharyngitis

Ectoin® Lozenges in the Treatment of Acute Viral Pharyngitis

Start date: January 2016
Phase: N/A
Study type: Observational

This a comparative, open label, parallel group, non interventional study which compares the tolerability and influence of Ectoin containing Lozenges to saline solution and lozenges containing hyaluronic acid for the treatment of acute viral Pharyngitis. The observation takes place over a period of 7 days. Response to treatment is recorded at day 1 and day 7 by the physician and by the patient in a dairy.